Lynne Fahey Mcgrath serves as Executive at Alzamend Neuro, Inc., where they oversee executive responsibilities. Since joining the company, Lynne Fahey Mcgrath has executed 8 insider transactions totaling $65.6K, demonstrating a bearish approach to their equity position. Their most recent transaction on Oct 23, 2025 involved selling 30 shares valued at $69.
Lynne Fahey Mcgrath currently holds 25 shares of Alzamend Neuro, Inc. (ALZN), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Lynne Fahey Mcgrath has been a net seller of ALZN stock. They have purchased $4.4K and sold $61.2K worth of shares.
Lynne Fahey Mcgrath's most recent insider trade was on Oct 23, 2025, when they sold 30 shares at $2.29 per share.
Get notified when new Form 4 filings are submitted
| $0.88 |
| Discretionary |
| Mar 22, 2023 | ALZN | $4.4K | Purchase | 10,000 | $0.44 | Discretionary |
| Mar 28, 2022 | ALZN | $30.3K | Sale | 25,000 | $1.21 | Discretionary |
| Mar 28, 2022 | ALZN | $30.3K | Sale | 25,000 | $1.21 | Discretionary |
| Mar 15, 2022 | ALZN | $0 | Option Exercise | 50,000 | $N/A | Discretionary |
| Oct 15, 2021 | ALZN | $0 | Option Exercise | 47,222 | $N/A | Discretionary |
| Sep 13, 2021 | ALZN | $0 | Option Exercise | 2,778 | $N/A | Discretionary |